Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda B Spurdle

Showing results (121-130 of 398) with videos related to

Pageof 40
Sort By:
Pharmacogenetics|July 27, 2002
The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancerAmanda B Spurdle, Bryan Goodwin, Ecushla Hodgson, et al.
Ebiomedicine|September 27, 2020
Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genesKeijiro Mizukami, Yusuke Iwasaki, Eiryo Kawakami, et al.
Breast Cancer Research and Treatment|December 26, 2006
Mutation analysis of five candidate genes in familial breast cancerAnna Marsh, Sue Healey, Aaron Lewis, et al.
Bioinformatics (Oxford, England)|November 27, 2018
A plugin for the Ensembl Variant Effect Predictor that uses MaxEntScan to predict variant spliceogenicityJannah Shamsani, Stephen H Kazakoff, Irina M Armean, et al.
Asia-Pacific Journal of Clinical Oncology|October 9, 2018
Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providersLyon Mascarenhas, Susan Shanley, Gillian Mitchell, et al.
Journal of the National Cancer Institute|June 20, 2019
Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 ControlsYukihide Momozawa, Yusuke Iwasaki, Makoto Hirata, et al.
Plos Genetics|May 24, 2008
BRCA1 and BRCA2 missense variants of high and low clinical significance influence lymphoblastoid cell line post-irradiation gene expressionNic Waddell, Anette Ten Haaf, Anna Marsh, et al.
Plos One|February 4, 2014
Multifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that BRCA1:c.122A>G(p.His41Arg) is a pathogenic mutationPhillip J Whiley, Michael T Parsons, Jennifer Leary, et al.
Genome Medicine|July 10, 2026
Combining multiplexed functional data to improve variant classificationJeffrey D Calhoun, Moez Dawood, Charlie F Rowlands, et al.
Genetic Epidemiology|March 26, 2003
Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancerJisheng S Cui, Amanda B Spurdle, Melissa C Southey, et al.
Pageof 40

Showing results (121-130 of 398) with videos related to

Sort By:
Pageof 40
Pharmacogenetics|July 27, 2002
The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancerAmanda B Spurdle, Bryan Goodwin, Ecushla Hodgson, et al.
Ebiomedicine|September 27, 2020
Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genesKeijiro Mizukami, Yusuke Iwasaki, Eiryo Kawakami, et al.
Breast Cancer Research and Treatment|December 26, 2006
Mutation analysis of five candidate genes in familial breast cancerAnna Marsh, Sue Healey, Aaron Lewis, et al.
Bioinformatics (Oxford, England)|November 27, 2018
A plugin for the Ensembl Variant Effect Predictor that uses MaxEntScan to predict variant spliceogenicityJannah Shamsani, Stephen H Kazakoff, Irina M Armean, et al.
Asia-Pacific Journal of Clinical Oncology|October 9, 2018
Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providersLyon Mascarenhas, Susan Shanley, Gillian Mitchell, et al.
Journal of the National Cancer Institute|June 20, 2019
Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 ControlsYukihide Momozawa, Yusuke Iwasaki, Makoto Hirata, et al.
Plos Genetics|May 24, 2008
BRCA1 and BRCA2 missense variants of high and low clinical significance influence lymphoblastoid cell line post-irradiation gene expressionNic Waddell, Anette Ten Haaf, Anna Marsh, et al.
Plos One|February 4, 2014
Multifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that BRCA1:c.122A>G(p.His41Arg) is a pathogenic mutationPhillip J Whiley, Michael T Parsons, Jennifer Leary, et al.
Genome Medicine|July 10, 2026
Combining multiplexed functional data to improve variant classificationJeffrey D Calhoun, Moez Dawood, Charlie F Rowlands, et al.
Genetic Epidemiology|March 26, 2003
Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancerJisheng S Cui, Amanda B Spurdle, Melissa C Southey, et al.
Pageof 40